Innovative and patented liquid biopsy solution based on circulating exosomes proteomics aims to revolutionize the life of millions of patients every year.
Biopsomic’s product consists in a proprietary prognostic score conducted in a centralized laboratory from a blood sample taken from a colorectal cancer patient
Primary Therapeutic Areas
1.5 Medical Technology
1.52 Diagnostic & In-Vitro Device
c/o Gotham Lab Sàrl, Avenue d'Ouchy 4
1006 Lausanne / VD